ストックスクリーナーアプリを入手
71.53
2.50%
1.65
前日終値:
$69.88
開ける：
$70.07
24時間の取引高:
1.23M
Relative Volume:
0.56
時価総額：
$13.83B
収益：
$29.52M
当期純損益:
$-567.06M
株価収益率:
-19.54
EPS:
-3.66
ネットキャッシュフロー:
$-551.11M
1週間 パフォーマンス:
+5.72%
1か月 パフォーマンス:
+33.90%
6か月 パフォーマンス:
+84.89%
1年 パフォーマンス:
+26.14%
1日の値動き範囲:
$69.50
$71.97
1週間の範囲:
$67.27
$72.72
52週間の値動き範囲:
$29.17
$72.72
Revolution Medicines Inc Stock (RVMD) Company Profile
名前
Revolution Medicines Inc
セクター
電話
415-766-3638
住所
700 SAGINAW DR, REDWOOD CITY, CA
RVMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
71.53 | 13.51B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.06 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
760.89 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
437.57 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.65 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.09 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 開始されました | Wolfe Research | Outperform |
| 2025-11-03 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-10-21 | 開始されました | Mizuho | Outperform |
| 2025-10-16 | 再開されました | Stifel | Buy |
| 2025-09-12 | 再開されました | Raymond James | Strong Buy |
| 2025-09-05 | 開始されました | Truist | Buy |
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2025-08-15 | 開始されました | Wells Fargo | Overweight |
| 2025-07-15 | 開始されました | Goldman | Buy |
| 2024-07-16 | 繰り返されました | Needham | Buy |
| 2024-07-12 | 開始されました | Barclays | Overweight |
| 2024-07-08 | 開始されました | Jefferies | Buy |
| 2024-04-12 | 繰り返されました | Needham | Buy |
| 2024-04-10 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | 開始されました | Piper Sandler | Overweight |
| 2024-01-05 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-01-04 | 開始されました | Wedbush | Outperform |
| 2023-11-16 | 開始されました | Raymond James | Outperform |
| 2023-02-28 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-12-14 | 開始されました | Needham | Buy |
| 2022-10-21 | 開始されました | Oppenheimer | Outperform |
| 2022-05-20 | 開始されました | BofA Securities | Neutral |
| 2022-03-01 | アップグレード | Stifel | Hold → Buy |
| 2021-09-23 | 開始されました | Stifel | Hold |
| 2021-08-12 | ダウングレード | Goldman | Buy → Neutral |
| 2021-05-18 | 開始されました | Goldman | Buy |
| 2020-05-21 | 開始されました | H.C. Wainwright | Buy |
| 2020-03-09 | 開始されました | Cowen | Outperform |
| 2020-03-09 | 開始されました | Guggenheim | Buy |
| 2020-03-09 | 開始されました | JP Morgan | Neutral |
すべてを表示
Revolution Medicines Inc (RVMD) 最新ニュース
Revolution Medicines (NASDAQ:RVMD) Upgraded at Wolfe Research - MarketBeat
Why Revolution Medicines Inc. (42Z) stock could rally strongly2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
Revolution Medicines Insider Sold Shares Worth $939,008, According to a Recent SEC Filing - MarketScreener
Revolution Medicines Insider Sold Shares Worth $1,407,586, According to a Recent SEC Filing - MarketScreener
Police & Firemen s Retirement System of New Jersey Boosts Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Can Revolution Medicines Inc. Equity Warrant stock withstand economic slowdownTrade Volume Report & High Conviction Trade Alerts - newser.com
Catalyst Funds Management Pty Ltd Takes Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Will Revolution Medicines Inc. (42Z) stock boost dividends further2025 Market Trends & Fast Entry Momentum Trade Alerts - newser.com
Why Revolution Medicines Inc. Equity Warrant stock remains a top recommendationMarket Movers & Accurate Buy Signal Notifications - newser.com
Should I hold or sell Revolution Medicines Inc. Equity Warrant stock in 2025Entry Point & Verified Technical Trade Signals - newser.com
How Revolution Medicines Inc. stock performs in rising dollar environment2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com
What MACD and RSI say about Revolution Medicines Inc. Equity Warrant2025 Price Momentum & Weekly Setup with ROI Potential - newser.com
Using Bollinger Bands to evaluate Revolution Medicines Inc. Equity WarrantQuarterly Portfolio Review & Risk Managed Investment Strategies - newser.com
What makes Revolution Medicines Inc. (42Z) stock appealing to growth investors2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Is Revolution Medicines Inc. Equity Warrant stock a buy on dips2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Revolution Medicines Inc. stock trend outlook and recovery pathDividend Hike & Stepwise Trade Execution Plans - newser.com
Is Revolution Medicines Inc. stock a bargain at current levels2025 Analyst Calls & Real-Time Buy Zone Alerts - newser.com
Wolfe Research Initiates Coverage on Revolution Medicines (NASDAQ:RVMD) - MarketBeat
How Revolution Medicines Inc. (42Z) stock reacts to weak economy2025 Market Trends & Risk Adjusted Swing Trade Ideas - newser.com
Revolution Medicines (NASDAQ:RVMD) Sets New 12-Month HighHere's Why - MarketBeat
Why Revolution Medicines Inc. (42Z) stock is a strong analyst pickTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
What institutional flow reveals about Revolution Medicines Inc. Equity Warrant2025 Volatility Report & Fast Entry High Yield Tips - newser.com
Is Revolution Medicines Inc. a candidate for recovery playBull Run & Technical Entry and Exit Alerts - newser.com
Is Revolution Medicines Inc. Equity Warrant showing signs of accumulationEarnings Beat & Technical Buy Zone Confirmation - newser.com
What analysts say about Revolution Medicines Inc stockFundamental Stock Analysis & High Yield Investment Tips - earlytimes.in
Is a relief rally coming for Revolution Medicines Inc. holdersCEO Change & Consistent Growth Equity Picks - newser.com
RVMD: Wolfe Research Initiates Coverage with Outperform Rating a - GuruFocus
Market reaction to Revolution Medicines Inc. Equity Warrant’s recent newsSell Signal & Safe Entry Point Identification - newser.com
Revolution Medicines, Inc. $RVMD Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
How Revolution Medicines Inc. Equity Warrant stock performs in rising dollar environmentWeekly Risk Summary & Weekly Watchlist for Hot Stocks - newser.com
Revolution Medicines is 'within sight' of 1,000 employees and looking for a new office to fit them - The Business Journals
What to expect from Revolution Medicines Inc. Equity Warrant in the next 30 daysTrade Analysis Summary & Safe Entry Trade Reports - newser.com
Revolution Medicines, Inc. $RVMD Shares Sold by Bank of New York Mellon Corp - MarketBeat
Revolution Medicines Insider Sold Shares Worth $1,301,410, According to a Recent SEC Filing - MarketScreener
Technical signs of recovery in Revolution Medicines Inc.July 2025 Setups & Weekly Breakout Stock Alerts - newser.com
Will Revolution Medicines Inc. Equity Warrant stock remain a Wall Street favoriteMarket Risk Analysis & Real-Time Stock Entry Alerts - newser.com
Revolution Medicines (NASDAQ:RVMD) Insider Sells $1,301,400.00 in Stock - MarketBeat
Revolution Medicines Inc. Equity Warrant stock retracement – recovery analysisPortfolio Value Report & Intraday High Probability Setup Alerts - newser.com
Why Revolution Medicines Inc. stock is in analyst buy zone2025 Geopolitical Influence & Consistent Growth Equity Picks - newser.com
Do Ongoing Losses at Revolution Medicines (RVMD) Reflect Strategic R&D Commitment or Financial Strain? - simplywall.st
Revolution Medicines Inc (RVMD) 財務データ
収益
当期純利益
現金流量
EPS
Revolution Medicines Inc (RVMD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| GOLDSMITH MARK A | See Remarks |
Nov 18 '25 |
Sale |
70.38 |
20,000 |
1,407,586 |
247,863 |
| Cislini Jeff | General Counsel |
Nov 18 '25 |
Option Exercise |
42.45 |
13,388 |
568,321 |
63,813 |
| Cislini Jeff | General Counsel |
Nov 18 '25 |
Sale |
70.14 |
13,388 |
939,008 |
50,425 |
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):